Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Nitric Oxide
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Undisclosed
Recipient : Fernando Suarez Sipmann
Deal Size : Inapplicable
Deal Type : Inapplicable
Role of Inhaled Nitric Oxide in Vascular Mechanics and Right Ventricular Function
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 24, 2023
Lead Product(s) : Nitric Oxide
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Undisclosed
Recipient : Fernando Suarez Sipmann
Deal Size : Inapplicable
Deal Type : Inapplicable
EMONO for the Treatment of Peripheral Neuropathic Pain
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
November 08, 2016
Lead Product(s) : Nitrous Oxide
Therapeutic Area : Neurology
Study Phase : Phase I
Sponsor : ORION Clinical Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 20, 2012
Lead Product(s) : Nitrous Oxide
Therapeutic Area : Neurology
Highest Development Status : Phase I
Sponsor : ORION Clinical Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Helium
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase II
Sponsor : Asklepios Kliniken Hamburg
Deal Size : Inapplicable
Deal Type : Inapplicable
Six-Minute Walk Test Comparing Helium/Oxygen to Nitrogen/Oxygen for COPD Rehabilitation
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 18, 2011
Lead Product(s) : Helium
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase II
Sponsor : Asklepios Kliniken Hamburg
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Xenon
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Orion Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 11, 2011
Lead Product(s) : Xenon
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Orion Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Hip Fracture Surgery in Elderly Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 10, 2010
Lead Product(s) : Helium
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 01, 2010
Lead Product(s) : Helium
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Xenon
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Eurofins Biomnis | Monitoring Force Group | Inferential
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 11, 2010
Lead Product(s) : Xenon
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Eurofins Biomnis | Monitoring Force Group | Inferential
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Xenon
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Sympathetic Neural Outflow During Xenon Anesthesia in Humans
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 06, 2010
Lead Product(s) : Xenon
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable